Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is focused on developing a network of addiction treatment clinics and undertake a planned clinical trial for research into the use of ibogaine for addiction treatment. Ibogaine is a naturally-occurring molecule derived from the root bark of the iboga tree and other plants. Ibogaine is a neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated effectiveness in treating opioid use disorder and it appears to eliminate the painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Ibogaine targets multiple receptor sites in the brain when it manages dopamine and serotonin circuits and stimulates new brain cell growth.


TSXV:IBO - Post by User

Post by AbbasHaideron Oct 12, 2021 3:13pm
73 Views
Post# 33998362

Universal Ibogaine is using alternative addiction treatments

Universal Ibogaine is using alternative addiction treatmentsBNN Bloomberg published an article about Universal Ibogaine Inc. The article discusses how current treatments are not effective in combatting drug addicition and Universal Ibogaine's alternative medicine treatment methods.

Universal Ibogaine’s focus on opioid addiction stems from a current limited effectiveness of substitution treatments that replace illicit potent opioids with less potent opioids that can be monitored. Unfortunately, the results of this method have not been sufficiently effective. As Dr. Rami Batal, CEO of Universal Ibogaine notes, “If you look at the relapse rate with substitution treatments, within a year, you might see nine out of ten patients relapse. And although every bit helps, and substitution therapy constitutes a good start in battling this complex illness, a success rate of 10 per cent clearly leaves much to be desired”
 

The company is developing a holistic and involved care model, ultimately to be centered on ibogaine detox, which views and tackles addiction as the complex, chronic, disease that it is. Addiction is at least as complicated as for example diabetes, and the approach to treating it should be equally multi-modal and prolonged. The company’s clinical approach will involve using ibogaine to disrupt addiction, eliminate cravings for several months, and create a window of clarity for patients in which multiple compatible and complimentary treatment modalities can be applied. The intent is to treat addiction by also addressing the underlying causes of addiction and concurrent mental and behavioral health disorders, such as depression and anxiety.

Find out more about Universal Ibogaine Inc: https://universalibogaine.com/

Read the full article: https://www.bnnbloomberg.ca/universal-ibogaine-is-spearheading-a-new-approach-to-addiction-treatment-1.1662167

<< Previous
Bullboard Posts
Next >>